| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| KES | |||||||
| Peginterferon Alfa-2a More info | |
|---|---|
| Drug Indication | Hepatitis C viral infection |
| Side Effects | Influenza-like syndrome (most common S/E; anorexia; weight loss; alopecia; bone marrow depression; hepatic disturbances; renal disturbance; hypotension (sometimes hypertension), arrhythmias, myocardial infarction; stroke; ataxia; somnolences; confusion; severe fatigue; depression; visual disturbances |
| Dosage | 135-180 mcg weekly |
| Mode Of Action
Contraindications |
Poly ethylene glycol PEG polymers enhance pharmacokinetics and pharmacodynamic properties of interferon a and other proteins. It has anti viral properties |